Recent investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are demonstrating significant results in treating weight gain and diabetes second-type condition. Initial evidence suggest a unique https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/